Note 11 - Segment Information

6 Months Ended

Jun. 30, 2023

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

(11)        Segment Information

The Company has four reportable segments which include: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, and Fluorine Products.

Information regarding the operations and assets of these reportable business segments is contained in the following table:

	Three months ended June 30,				Six months ended June 30,
Sale of Product	2023		2022		2023		2022
Radiochemical Products	$	1,736,043	$	1,380,039	$	3,498,439	$	3,005,962
Cobalt Products		448,258		99,146		606,566		271,052
Nuclear Medicine Standards		927,864		955,623		2,096,695		1,965,235
Fluorine Products		—		—		—		—
Total Segments		3,112,165		2,434,808		6,201,700		5,242,249
Corporate revenue		—		—		—		—
Total Consolidated	$	3,112,165	$	2,434,808	$	6,201,700	$	5,242,249

	Three months ended June 30,				Six months ended June 30,
Depreciation and Amortization	2023		2022		2023		2022
Radiochemical Products	$	6,665	$	7,415	$	13,824	$	49,345
Cobalt Products		13,142		12,140		25,976		24,281
Nuclear Medicine Standards		28,900		28,587		58,109		57,233
Fluorine Products		28,970		26,095		57,940		52,190
Total Segments		77,677		74,237		155,849		183,049
Corporate depreciation and amortization		10,453		10,196		19,549		20,502
Total Consolidated	$	88,130	$	84,433	$	175,398	$	203,551

	Three months ended June 30,						Six months ended June 30,
Segment Income (Loss)	2023			2022			2023			2022
Radiochemical Products	$	717,455		$	505,630		$	1,484,567		$	2,976,293
Cobalt Products		53,640			(42,332	)		27,395			(55,407	)
Nuclear Medicine Standards		9,728			(26,144	)		138,513			11,572
Fluorine Products		(21,895	)		(42,343	)		(51,134	)		(74,173	)
Total Segments		758,928			394,811			1,599,341			2,858,285
Corporate loss		(1,022,230	)		(666,859	)		(2,010,697	)		(1,875,288	)
Net Income	$	(263,302	)	$	(272,048	)	$	(411,356	)	$	982,997

	Three months ended June 30,				Six months ended June 30,
Expenditures for Segment Assets	2023		2022		2023		2022
Radiochemical Products	$	—	$	—	$	—	$	—
Cobalt Products		6,165		—		6,165		—
Nuclear Medicine Standards		—		—		3,130		51,100
Fluorine Products		—		4,100		—		4,100
Total Segments		6,165		4,100		9,295		55,200
Corporate purchases		8,155		—		57,227		—
Total Consolidated	$	14,320	$	4,100	$	66,522	$	55,200

	June 30,		December 31,
Segment Assets	2023		2022
Radiochemical Products	$	837,771	$	1,075,252
Cobalt Products		324,755		406,629
Nuclear Medicine Standards		2,661,330		2,744,394
Fluorine Products		5,032,308		5,147,325
Total Segments		8,856,164		9,373,600
Corporate assets		6,981,112		6,870,996
Total Consolidated	$	15,837,276	$	16,244,596